Table 5.
NEK2, JMJD4 and REST expression in stained tissues and association with progression and survival rates of the ccRCC patients
| ccRCC | Total N=100 |
NEK2 | P | JMJD4 | P | REST | P | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Low N=58 |
High N=42 |
Low N=38 |
High N=62 |
Low N=76 |
High N=24 |
||||||
| Progression | Absent | 44 (44.0%) | 18 (85.7%) | 13.8 (13.8%) | <0.001 | 89.5 (89.5%) | 5 (16.1%) | <0.001 | 34.2 (34.2%) | 75 (75.0%) | 0.013 |
| Present | 56 (56.0%) | 3 (14.3%) | 86.2 (86.2%) | 10.5 (10.5%) | 83.9 (83.9%) | 65.8 (65.8%) | 25 (25.0%) | ||||
| Survival status | Censored | 58 (58.0%) | 21 (100.0%) | 27.6 (27.6%) | <0.001 | 100 (100.0%) | 32.3 (32.3%) | <0.001 | 50 (50.0%) | 83.3 (83.3%) | 0.041 |
| Died | 42 (42.0%) | 0 (0.0%) |
72.4 (72.4%) | 0 (0.0%) |
67.7 (67.7%) | 50 (50.0%) | 16. 7 (16.7%) | ||||